HOME >> BIOLOGY >> NEWS
Identifying cancer genes Will it really lead to better treatment?

Copenhagen, Denmark: A systematic trawl through the human genome looking for the abnormalities that drive cancer is already producing promising results, a scientist told ECCO 12 The European Cancer Conference in Copenhagen today (Tuesday 23 September). Dr. Michael Stratton, Director of the Cancer Genome Project at the Wellcome Trust Sanger Institute, Cambridge, UK, described how his study of the BRAF mutation could provide new targets for drug development, which could lead to better targeted or even individualised - treatment for cancer patients.

The decoding of the human genome has allowed scientists to compare the normal DNA sequence with that seen in cancers, and hence identify abnormalities. The BRAF mutation is implicated in a number of common cancers, according to Dr. Stratton. It appears to be involved in the switching mechanism of the gene, and is found in 70% of melanomas, in 30% of some types of thyroid and ovarian cancer, and in 10% of colorectal tumours. Over 80% of the mutations bring about a single change in an amino acid, making it a relatively simple target for rectification. "Once we can identify this kind of abnormal biological process", said Dr. Stratton. "we can move on to the next stage developing drugs to prevent or correct it."

The traditional approach to research in cancer has been the comparison of treatments through randomised clinical trials, with the extrapolation of an average benefit to the individual. This often means that many patients are inefficiently treated, while only a few benefit. Gene targets herald a different approach, and are becoming increasingly important in the search for effective cancer treatments. Genes are implicated in cancer in a number of ways as oncogenes, which drive cancer forward, as tumour suppressor genes that slow down cell division, and as DNA repair genes, which help to keep chromosomes intact when genetic mutation occurs.

A small number of drugs targeted at mutated
'"/>

Contact: Margaret Willson
m.willson@mwcommunications.org.uk
45-3252-4179
Federation of European Cancer Societies
23-Sep-2003


Page: 1 2

Related biology news :

1. Identifying tick genes could halt disease, bioterrorism threat
2. Identifying individuals at risk for Alzheimers disease
3. Identifying novel small RNAs
4. Breakthrough in genomic technology: Identifying the biologically relevant parts of the human genome
5. Leader in cancer treatment and prevention research honored
6. International study findings link acne-like rash to effectiveness of new targeted cancer treatment
7. Chemical derived from vitamin-E shows early promise as cancer drug
8. New molecular link key to cellular proteins involved in cancer progression, other diseases
9. Phase II trials of second-generation antisense cancer drug planned following successful early study
10. Trial shows which brain cancer patients benefit from temozolomide
11. Genetic differences might help distinguish thyroid cancers

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/5/2018)... ... December 04, 2018 , ... Urological Associates ... a UroLift® Center of Excellence. The designation recognizes that Dr. Choi has achieved ... a commitment to exemplary care for men suffering from symptoms associated with Benign ...
(Date:11/29/2018)... ... November 29, 2018 , ... Tosoh ... the intention of acquiring full ownership. The transaction was approved by the Board ... November 14, 2018. “We are extremely pleased to team up with Tosoh Bioscience ...
(Date:11/27/2018)... N.J. and CARLSBAD, Calif. (PRWEB) , ... November ... ... John Wiley & Sons. The companies have worked together to integrate the ... TAs and students. The combined offering will be available beginning January of ...
Breaking Biology News(10 mins):
(Date:11/9/2018)... N.H. and PHILADELPHIA (PRWEB) , ... November 08, ... ... 25-year-old control system integrator of custom industrial automation and IT solutions with 140 ... be exhibiting at Automation Fair®, taking place at the Pennsylvania Convention Center on ...
(Date:11/6/2018)... ... November 06, 2018 , ... Crucial ... trial data collection and management. TrialKit ™, an eClinical platform, has incorporated ... can quickly and easily sign in to the app via facial recognition or ...
(Date:11/5/2018)... NEW YORK (PRWEB) , ... November 05, 2018 ... ... test, is launching live educational support for healthcare professionals through its website, ... support will offer a live chat and video option via the website in ...
(Date:11/3/2018)... N.C. (PRWEB) , ... November 01, 2018 , ... Triangle ... by Inc. Magazine as one of the fastest-growing private companies in the United States, ... Inc. 5000 list ranks private companies based on percentage revenue growth over the previous ...
Breaking Biology Technology:
Cached News: